Details

Archived - Consultation on the Revised Guidance for Industry Preparation of the Quality Information for Drug Submissions in the CTD Format: Biotherapeutic and Blood Products - Canada.ca

Metadata and links for an archived snapshot.

Source: Health Canada
Date: Mar 6, 2026 · edition #6
Timestamp: 2026-03-06T02:32:29.031Z
Language: en
Original URL: https://www.canada.ca/en/health-canada/programs/consultation-revised-guidance-drug-submissions-ctd-biotherapeutic-blood-products.html
Replay URL: https://replay.healtharchive.ca/job-6/20260306023229/https://www.canada.ca/en/health-canada/programs/consultation-revised-guidance-drug-submissions-ctd-biotherapeutic-blood-products.html#ha_snapshot=605601
ID: 605601
Status: 200
Type: text/html

Independent archive · Not an official government website. For up-to-date recommendations, always consult the official source website.

Other snapshots